Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,706 | 301 | 99.6% |
| Education | $20.58 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,571 | 105 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $671.90 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $371.66 | 27 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $270.04 | 6 | $0 (2022) |
| Grifols USA, LLC | $225.19 | 24 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $174.53 | 17 | $0 (2019) |
| PFIZER INC. | $160.61 | 11 | $0 (2024) |
| United Therapeutics Corporation | $124.44 | 7 | $0 (2024) |
| Genentech USA, Inc. | $112.24 | 9 | $0 (2022) |
| GENZYME CORPORATION | $95.46 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $481.87 | 34 | GlaxoSmithKline, LLC. ($159.57) |
| 2023 | $721.21 | 26 | GlaxoSmithKline, LLC. ($395.65) |
| 2022 | $795.88 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($205.79) |
| 2021 | $775.58 | 48 | GlaxoSmithKline, LLC. ($186.98) |
| 2020 | $595.11 | 41 | GlaxoSmithKline, LLC. ($303.84) |
| 2019 | $486.99 | 25 | GlaxoSmithKline, LLC. ($176.18) |
| 2018 | $483.44 | 46 | Sunovion Pharmaceuticals Inc. ($110.90) |
| 2017 | $386.81 | 32 | GlaxoSmithKline, LLC. ($130.60) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Pulmonology | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 878 | 1,360 | $263,228 | $113,992 |
| 2022 | 17 | 780 | 1,127 | $213,372 | $91,121 |
| 2021 | 22 | 1,095 | 1,639 | $322,469 | $138,002 |
| 2020 | 22 | 1,107 | 1,592 | $306,531 | $136,569 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 208 | 478 | $97,512 | $42,871 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 242 | $38,770 | $21,247 | 54.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 41 | 99 | $33,660 | $16,050 | 47.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 95 | $25,650 | $12,682 | 49.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 125 | $16,250 | $7,549 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,570 | $1,991 | 55.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 17 | 20 | $10,600 | $1,857 | 17.5% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 11 | 11 | $5,500 | $1,806 | 32.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 19 | $3,610 | $1,656 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,860 | $1,270 | 44.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,860 | $1,270 | 44.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 26 | 26 | $2,470 | $971.91 | 39.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 21 | 21 | $1,995 | $749.93 | 37.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 15 | 21 | $6,300 | $524.79 | 8.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 13 | 13 | $1,183 | $337.08 | 28.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $314.93 | 81.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 29 | $348.00 | $243.60 | 70.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 18 | 18 | $1,710 | $165.06 | 9.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 22 | 22 | $3,410 | $137.28 | 4.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 18 | 18 | $1,710 | $122.04 | 7.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 15 | 15 | $2,625 | $117.60 | 4.5% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 25 | 25 | $250.00 | $58.00 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 170 | 321 | $65,484 | $25,226 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 236 | $37,910 | $21,083 | 55.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 126 | $42,840 | $21,008 | 49.0% |
About Dr. Aaron Bruns, M.D
Dr. Aaron Bruns, M.D is a Critical Care Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639394091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Bruns, M.D has received a total of $4,727 in payments from pharmaceutical and medical device companies, with $481.87 received in 2024. These payments were reported across 302 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,706).
As a Medicare-enrolled provider, Bruns has provided services to 3,860 Medicare beneficiaries, totaling 5,718 services with total Medicare billing of $479,685. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Greenwood, IN
- Active Since 04/13/2007
- Last Updated 01/13/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1639394091
Products in Payments
- NUCALA (Biological) $1,093
- OFEV (Drug) $391.15
- TRELEGY ELLIPTA (Drug) $343.28
- DUPIXENT (Biological) $170.72
- Prolastin-C Liquid (Biological) $157.70
- STIOLTO RESPIMAT (Drug) $126.46
- ELIQUIS (Drug) $107.02
- GLASSIA (Biological) $99.70
- SUNOSI (Drug) $97.95
- TYVASO (Drug) $94.80
- LONHALA MAGNAIR (Drug) $78.67
- XARELTO (Drug) $77.45
- TEZSPIRE (Biological) $74.73
- Prolastin-C (Biological) $67.49
- Xolair (Biological) $66.54
- BREZTRI (Drug) $65.89
- OPSUMIT MACITENTAN (Drug) $58.09
- NUZYRA (Drug) $57.00
- FASENRA (Biological) $53.41
- INSPIRE (Device) $52.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenwood
Dr. Sandeep Kukreja, M.d, M.D
Critical Care Medicine — Payments: $358,561
Dr. Faisal Khan, Md, MD
Critical Care Medicine — Payments: $169,121
Dr. Imad Shawa, Md, MD
Critical Care Medicine — Payments: $28,103
Dr. Winston Nara, Md, MD
Critical Care Medicine — Payments: $3,963
Dr. Ruxandra Ionescu, Md, MD
Critical Care Medicine — Payments: $1,763
Melinda Quarles, Msn, Rn, MSN, RN
Critical Care Medicine — Payments: $368.07